• New case-finding service for the detection of prostate cancer launches in Surrey and Sussex to speed up diagnosis

    16 August 2022

    A pilot project is being rolled out to 500 men across six GP practices within the Guildford East area of Surrey to offer a simple prostate test to eligible males.

  • NHS relaunches `Help Us, Help You' lung cancer campaign

    1 August 2022

  • NHS Targeted Lung Health Checks come to Sussex

    15 July 2022

    72,000 people aged 55 to 74 living in Brighton and Hove, and Crawley will be invited to an NHS lung health check over the next 18 months to improve earlier diagnosis of lung cancer and save lives

  • Cervical Screening Awareness Week 20-26 June 2022

    21 June 2022

    Raising the profile of cervical screening by sharing tips and experiences for those who find accessing screening appointments difficult

  • A record year for people receiving lifesaving NHS cancer checks

    3 May 2022

    NHS England announces that almost three million people were referred for cancer checks over the last 12 months.

  • New campaign to combat the fear of cancer

    1 March 2022

    NHS launches radical approach to encourage people not to delay `life-saving' checks

  • National campaign to encourage men to know their risk of prostate cancer and take action

    17 February 2022

    Prostate Cancer UK and NHS join forces to find 14,000 undiagnosed men who need urgent treatment

  • Cervical Screening Campaign launched

    14 February 2022

    Help Us Help You – Cervical Screening Campaign highlights the benefits of cervical screening and reminds people that it can help stop cancer before it starts.

  • SBRI success for PinPoint Data Science

    7 February 2022

    A new cancer diagnostic test is set to be trialled in Surrey and Sussex

  • Lung cancer patients to benefit from revolutionary new drug on NHS

    28 January 2022

    Thousands of lung cancer patients in England will be fast-tracked to a ground-breaking new drug which can significantly reduce the risk of cancer returning, thanks to a deal brokered by NHS England.